Personalized Self-Management Training Compared to Standardized Self-Management Training in Colorectal Cancer

What is the Purpose of this Study?

The purpose of this study is to examine the effectiveness and patient experiences of colorectal cancer survivors who complete a 6-week, personalized self-management training program called RISE compared to a standardized self-management training program. Researchers want to know whether there is a difference in adherence, effectiveness, and patient experience between the two lifestyle coaching programs. Participants will be randomly assigned to one of two programs and will have their first session with the occupational therapist (OT), who will oversee the RISE personalized self-management training program (PSMT) and the standardized self-management training program (SSMT). All study sessions are virtual and consist of 8 videoconference visits. The OT will work with participants to set goals and make positive lifestyle habits. All patients will be asked to complete questionnaires.


Eligibility

  • 1. Age ≥18 years at the time of consent.
  • 2. History of Stage I-III colorectal cancer (CRC) within the past 12 months prior to enrollment.
  • 3. Ability to speak, write, and read English sufficiently to allow for program participation.
  • 4. Identified by self-report as having willingness and interest to work on at least one lifestyle-related risk factor. Lifestyle-related risk factors include diet, physical activity, body composition, alcohol use.
Show more

Where can I participate?

Cedars-Sinai Cancer at SOCC : Ana Martin

More about this Clinical Trial

What is the full name of this clinical trial?

IIT2023-04-SLEIGHT-RISE-PSMT: A Prospective, Randomized, Single-Blind, Controlled, Double-Arm Study of RISE Personalized Self-Management Training Compared to Standardized Self-Management Training in Colorectal Cancer Patients

Study Details
Disease Type/Condition

Colon, Rectum

Principal Investigator

Sleight Warner, Alexandra (Alix)

Co-Investigators

Andrew Hendifar, Arash Asher, Jun Gong, Kevin Scher, Lauren J Amaral, Leland Green, Pamela Roberts, Patricia Thompson, Philip Chang, Sandy Takata, Sarah Salvy, Stephen Freedland

Age Group

Adult

Phase

II (Cancer Control)

IRB Number

STUDY00002879

ClinicalTrials.gov ID

NCT05984589

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?
Name

Ana Martin

Email
ana.martin@cshs.org
Study Detail
Disease Type/Condition

Colon, Rectum

Principal Investigator

Sleight Warner, Alexandra (Alix)

Age Group

Adult

Phase

II (Cancer Control)

IRB Number

IIT2023-04-SLEIGHT-RISE-PSMT

ClinicalTrials.gov ID

NCT05984589

Key Eligibility
ClinicalTrials.gov

Contact
Name

Ana Martin

Email
ana.martin@cshs.org